Anna Wallerstedt
Papers
9
Total Citations
1,094
H-Index
9
About
Anna Wallerstedt is a leading clinical researcher in urologic oncology, best known for her pivotal work comparing robot-assisted laparoscopic radical prostatectomy (RALP) with open retropubic radical prostatectomy (RRP) for prostate cancer. Her landmark 2015 study in *European Urology* (489 citations) provided critical, high-grade evidence on patient-reported outcomes, demonstrating that while RALP offers shorter hospital stays, it does not significantly improve long-term urinary continence or erectile function over open surgery—challenging assumptions behind the rapid adoption of robotic techniques. Wallerstedt’s research extends to functional preservation, notably showing that greater neurovascular bundle preservation during prostatectomy correlates with better urinary continence one year post-surgery (162 citations). She also led health economic analyses within the prospective multicenter LAPPRO trial, revealing that RALP incurs substantially higher costs without clear quality-of-life benefits (87 citations). Her work on thromboembolic complications in over 3,500 patients (85 citations) and long-term oncologic outcomes with median 10-year follow-up (51 citations) has shaped surgical safety standards. Through rigorous, prospective, controlled studies, Wallerstedt has provided surgeons and patients with evidence-based guidance on treatment trade-offs, making her a key figure in modern prostate cancer surgery research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9